Moneycontrol
HomeNewsBusinessDid mid-tier IT services firms like Mindtree, L&T Infotech, Mphasis and Hexaware fare as well as their larger counterparts during the September quarter?

Did mid-tier IT services firms like Mindtree, L&T Infotech, Mphasis and Hexaware fare as well as their larger counterparts during the September quarter?

Strong deal wins aided by vendor consolidation and client investments in technology saw most companies report year on year growth

November 02, 2020 / 14:19 IST
Story continues below Advertisement

It is not just large IT firms that have done well amid Covid-19. Mid-tier IT services firms, including L&T InfotechMphasis and Hexaware, have done well at the back of strong deal momentum in Q2 as clients begin to spend on technology.

Mindtree, however, hasn’t.

Story continues below Advertisement

However, IT executives warn that the uncertainty around Covid-19 remains. The second wave of the disease and lack of stimulus in the US might affect certain sectors, including banking and retail, they added.

September quarter performance

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show